An investigation on behalf of investors in St. Jude Medical, Inc. (Public, NYSE:STJ) over potential violations of Federal Securities Laws by St. Jude Medical, Inc. continues.

According to the investigation by a law firm the investigation on behalf of investors in St. Jude Medical, Inc. (Public, NYSE:STJ) focuses on potential violations of the federal securities laws by St. Jude Medical, Inc. (NYSE: STJ) based on whether a series of statements regarding St. Jude business, its prospects and its operations were materially false and misleading at the time they were made. St. Jude Medical, Inc., located in St. Paul, MN, develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular, Atrial Fibrillation and Neuromodulation Systems. St. Jude Medical, Inc. reported in 2007 Total Revenue of $3.77928billion with a Net Income of $559.04million and in 2008 Total Revenue of $4.36325billion with a Net Income of $384.33million. Shares of St. Jude Medical (STJ) traded recently at $38.19 per share, down from its 52weekHigh of $41.96 per share, $47.97 per share in August 2008, and over $53 per share in 2006.